Mini Review
Published on 06 Nov 2023
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1291920
- 4,710 views
- 15 citations
Type at least 3 characters
1,645 articles
Articles
Mini Review
Published on 06 Nov 2023
Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1306584
- 2,553 views
- 3 citations
Brief Research Report
Published on 01 Nov 2023
Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1297596
- 2,284 views
- 2 citations
Original Research
Published on 30 Oct 2023
Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1258018
- 4,553 views
- 2 citations
Original Research
Published on 26 Oct 2023
β-sitosterol alleviates dextran sulfate sodium-induced experimental colitis via inhibition of NLRP3/Caspase-1/GSDMD-mediated pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1218477
- 3,369 views
- 7 citations
Correction
Published on 26 Oct 2023
Corrigendum: Naringenin protects against acute pancreatitis-associated intestinal injury by inhibiting NLRP3 inflammasome activation via AhR signaling
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1295494
- 767 views
- 4 citations
Opinion
Published on 23 Oct 2023
Whether MTHFD2 plays a new role: from anticancer targets to anti-inflammatory disease
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1257107
- 1,662 views
Original Research
Published on 23 Oct 2023
Non-aromatizable androgens modulate the lipopolysaccharide induced expression of the P2X7 receptor in human adipocytes
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1251035
- 1,273 views
Editorial
Published on 17 Oct 2023
Editorial: Global excellence in inflammation pharmacology
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307503
- 1,788 views
Systematic Review
Published on 17 Oct 2023
A systematic review and meta-analysis of loratadine combined with montelukast for the treatment of allergic rhinitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1287320
- 3,683 views
- 3 citations
Original Research
Published on 13 Oct 2023
Evaluation of anti-inflammatory and immunomodulatory potential of Lawsone (2-hydroxy-1,4-naphthoquinone) using pre-clinical rodent model of rheumatoid arthritis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1279215
- 2,296 views
- 3 citations
Original Research
Published on 09 Oct 2023
Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferonβ in chronic periodontitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1232539
- 2,926 views
- 2 citations
Original Research
Published on 03 Oct 2023
Revealing the diagnostic value and immune infiltration of senescence-related genes in endometriosis: a combined single-cell and machine learning analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1259467
- 3,068 views
- 3 citations
Review
Published on 02 Oct 2023
Natural products modulate NLRP3 in ulcerative colitis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1265825
- 4,582 views
- 12 citations
Systematic Review
Published on 28 Sep 2023
Anti-inflammatory and antioxidant activity of ursolic acid: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1256946
- 4,191 views
- 9 citations
Original Research
Published on 28 Sep 2023
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1239025
- 7,443 views
- 19 citations